Health
ERS Genomics Appoints Michael Arciero As Vice-President of Intellectual Property & Commercial Development – Technology Networks
Michael previously led the technology transfer team at USC Stevens Center for Innovation in his capacity as Director of Technology Commercialisation.
ERS Genomics Limited (ERS), which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property (IP) co-owned by Dr. Emmanuelle Charpentier, today announced the appointment of Michael Arciero as Vice-President of Intellectual Property and Commercial Development. In the new role, Michael will oversee the intellectual property portfolio of the company and will become a core member of the Company’s global business development team.Michael has over 15 years of experience i…
-
Business16 hours agoWhy did this ASX 200 healthcare stock crash 14% yesterday?
-
General24 hours agoRussia launches hundreds of drones and missiles against Ukraine in fresh attack
-
General16 hours agoPatients speak out after Brisbane doctor accused of ‘excessive’ pap smears, kissing woman on lips
-
Business15 hours agoHere’s what analysts expect for the BHP share price in the coming year